Tilray® Announces Support for Study Led by University of Sydney Examining the Effects of Driving under the Influence of Cannabis
The study led by The Lambert Initiative for Cannabinoid
Therapeutics at The
“The Effects of Medicinal Cannabinoids on Driving” study was a double
blind, placebo-controlled study that compared the effects of two
varieties of cannabis – a variety containing high levels of THC and a
variety containing a 1:1 balanced ratio of THC:CBD – to a placebo, which
contained neither THC nor CBD.
“We studied the extent to which cannabis affects driving and
specifically, whether CBD moderates the effects of THC,” says
The trial phase of this study was completed in 2018 and the published results are expected in 2019.
“We’re proud to support this important research,” says Dr.
About
Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients in twelve countries spanning five continents.
This press release contains “forward-looking statements”, which may
be identified by the use of words such as, “may”, “would”, “could”,
“will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”,
“forecast”, “project”, “estimate”, “outlook” and other similar
expressions. Forward-looking statements are not a guarantee of future
performance and are based upon a number of estimates and assumptions of
management in light of management’s experience and perception of trends,
current conditions and expected developments, as well as other factors
that management believes to be relevant and reasonable in the
circumstances, including assumptions in respect of current and future
market conditions, the current and future regulatory environment and
future approvals and permits. Actual results, performance or achievement
could differ materially from that expressed in, or implied by, any
forward-looking statements in this press release, and, accordingly, you
should not place undue reliance on any such forward-looking statements
and they are not guarantees of future results. Forward-looking
statements involve significant risks, assumptions, uncertainties and
other factors that may cause actual future results or anticipated events
to differ materially from those expressed or implied in any
forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181206005156/en/
Source:
Media Contact, Australia: Oryana Angel, 0400-602-202, oryana@inthemediapr.com.au
Media
Contact, Global: news@tilray.com,
1-833-206-8161
Media Contact, University of Sydney: Daniel
Gaffney, +61 2 9351 4630, daniel.gaffney@sydney.edu.au
Contact
for Investors: Katie Turner, +1-646-277-1228, Katie.turner@icrinc.com